Ex-Novartis Oncology Leader Riva Takes On Challenge Of Transgene Turnaround

Can Its Oncolytic Virus And Therapeutic Vaccine Platforms Finally Come Good?

 
• By Andrew McConaghie
  
Cancer cell
The concept of using viruses to stimulate an immune response to cancers has been around a long time, but has so far yielded no major successes.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip